Structures by: Tocher D. A.
Total: 212
Racemic progesterone
C21H30O2
Chemical Communications (2006) 47
a=10.9219(17)Å b=7.4400(12)Å c=21.034(3)Å
α=90.00° β=93.362(3)° γ=90.00°
Dtag018
C27H26.67AgF3N6O5.33S
Chemical communications (Cambridge, England) (2004) 12 1352-1353
a=7.1774(5)Å b=16.7930(15)Å c=19.6054(18)Å
α=107.586(3)° β=93.998(3)° γ=91.066(4)°
DTAg005
C27H30AgN7O6
Chemical communications (Cambridge, England) (2004) 12 1352-1353
a=49.675(4)Å b=13.4895(10)Å c=33.477(3)Å
α=90.00° β=122.132(7)° γ=90.00°
C52H52Ag2N12O8S
C52H52Ag2N12O8S
Chemical communications (Cambridge, England) (2004) 12 1352-1353
a=17.4146(6)Å b=17.4146(6)Å c=8.2655(6)Å
α=90.00° β=90.00° γ=90.00°
C18H17NO
C18H17NO
Chemical communications (Cambridge, England) (2009) 46, 2 318-320
a=18.680(2)Å b=7.2722(8)Å c=19.090(2)Å
α=90.00° β=90.00° γ=90.00°
C21H26ClNO4
C21H26ClNO4
Chemical communications (Cambridge, England) (2009) 46, 2 318-320
a=14.9657(13)Å b=12.7574(11)Å c=10.6945(9)Å
α=90.00° β=90.813(2)° γ=90.00°
Tetrachlorobenzene - alpha polymorph
C6H2Cl4
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.8016(5)Å b=10.6369(15)Å c=9.4866(13)Å
α=92.072(2)° β=98.966(2)° γ=96.520(2)°
1,2,4,5-tetrachlorobenzene - alpha polymorph
C6Cl4D2
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.79900(10)Å b=10.62580(10)Å c=9.47938(7)Å
α=91.9780(9)° β=99.058(2)° γ=96.234(2)°
1,2,4,5-tetrachlorobenzene - beta polymorph
C6Cl4D2
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.78988(4)Å b=10.50328(5)Å c=9.56244(3)Å
α=90° β=99.7184(6)° γ=90°
1,2,4,5-tetrachlorobenzene - beta polymorph
C6Cl4D2
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.85595(5)Å b=10.61473(6)Å c=9.59283(4)Å
α=90° β=99.6884(7)° γ=90°
1,2,4,5-tetrachlorobenzene - beta polymorph
C6Cl4D2
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.81117(4)Å b=10.53867(4)Å c=9.57198(3)Å
α=90° β=99.7088(5)° γ=90°
1,2,4,5-tetrachlorobenzene - alpha polymorph
C6Cl4D2
Acta Crystallographica Section B (2006) 62, 2 287-295
a=3.76062(4)Å b=10.58794(5)Å c=9.44562(3)Å
α=92.4066(4)° β=98.6978(6)° γ=97.5893(6)°
[Butane-2,3-dione bis(4-methylthiosemicarbazonato)-κ^4^<i>S</i>,<i>N</i>^1^,<i>N</i>^1^,<i>S</i>'](pyridine-κ<i>N</i>)zinc(II)
C13H19N7S2Zn
Acta Crystallographica Section E (2015) 71, 11 1349-1351
a=10.1466(2)Å b=13.9076(3)Å c=12.7775(3)Å
α=90° β=104.756(2)° γ=90°
Triethylenediaminium dichloride dihydrate
C6H14N22,2Cl,2H2O
Acta Crystallographica Section E (2005) 61, 7 o2202-o2204
a=7.1407(8)Å b=8.7188(10)Å c=16.8945(19)Å
α=90.00° β=90.00° γ=90.00°
4-Amino-5-fluoropyrimidin-2(1H)-one--2-amino-5-fluoropyrimidin-4(3H)-one--water (1/1/1)
C4H4FN3O,C4H4FN3O,H2O
Acta Crystallographica Section E (2005) 61, 7 o2112-o2113
a=5.4122(16)Å b=8.447(2)Å c=12.083(4)Å
α=89.454(5)° β=85.718(5)° γ=77.096(4)°
Butyramide
C4H9NO
Acta Crystallographica Section E (2005) 61, 7 o1985-o1986
a=9.814(3)Å b=5.9232(17)Å c=9.701(3)Å
α=90.00° β=112.070(4)° γ=90.00°
5,5-dihydroxybarbituric acid monohydrate
C4H4N2O5,H2O1
Acta Crystallographica Section E (2004) 60, 10 o1689-o1690
a=6.6730(11)Å b=7.5834(13)Å c=7.6157(13)Å
α=105.401(3)° β=93.134(3)° γ=115.089(2)°
5-Fluorouracil Dimethylformamide (2/1)
2C4H3FN2O2,C3H7NO
Acta Crystallographica Section E (2004) 60, 10 o1783-o1785
a=14.7361(18)Å b=5.8693(7)Å c=16.397(2)Å
α=90.00° β=100.524(2)° γ=90.00°
5,5-dihydroxybarbituric acid trihydrate
C4H4N2O5,3H2O
Acta Crystallographica Section E (2004) 60, 10 o1748-o1750
a=9.4614(8)Å b=12.2095(10)Å c=7.2973(6)Å
α=90.00° β=91.4650(10)° γ=90.00°
5-Fluorouracil 1,4-dioxane (4/1)
C4H8O2,4C4H3FN2O2
Acta Crystallographica Section E (2004) 60, 10 o1781-o1782
a=7.0847(11)Å b=8.4733(13)Å c=10.2291(15)Å
α=98.128(3)° β=96.913(3)° γ=99.785(3)°
5-Fluorouracil Dimethylsulfoxide (1/1)
C2H6OS,C4H3FN2O2
Acta Crystallographica Section E (2004) 60, 10 o1786-o1787
a=9.8831(10)Å b=10.8128(11)Å c=8.6842(9)Å
α=90.00° β=107.397(2)° γ=90.00°
5-fluorouracil--2,2,2-trifluoroethanol (1/1)
C4H3FN2O2,C2H3F3O
Acta Crystallographica Section E (2005) 61, 11 o3661-o3663
a=5.3976(6)Å b=6.7062(8)Å c=12.1098(14)Å
α=90° β=102.807(2)° γ=90°
Cyclohexane-1,3-dicarboximide, acetic acid (1/1)
C8H11NO2,C2H4O2
Acta Crystallographica Section E (2006) 62, 2 o545-o547
a=6.6224(7)Å b=7.3580(8)Å c=10.7995(12)Å
α=103.598(2)° β=93.378(2)° γ=97.272(2)°
4-Chloro-1,2-dinitrobenzene--1,4-dioxane (1/1)
C6H3ClN2O4,C4H8O2
Acta Crystallographica Section E (2006) 62, 4 o1662-o1663
a=8.2976(12)Å b=8.7112(13)Å c=8.8015(13)Å
α=103.661(2)° β=103.909(2)° γ=91.718(2)°
Metaldehyde
C8H16O4
Acta Crystallographica Section E (2005) 61, 4 o857-o859
a=10.4974(10)Å b=10.4974(10)Å c=4.0967(7)Å
α=90.00° β=90.00° γ=90.00°
Adeninium(2+) dichloride
C5H7N52,2Cl
Acta Crystallographica Section E (2005) 61, 4 o1052-o1054
a=13.4405(11)Å b=6.4774(5)Å c=9.3684(7)Å
α=90.00° β=90.00° γ=90.00°
Guaninium chloride dihydrate
C5H6N5O,Cl,2H2O
Acta Crystallographica Section E (2005) 61, 4 o1023-o1025
a=4.8587(11)Å b=13.228(3)Å c=14.612(3)Å
α=90.00° β=93.862(4)° γ=90.00°
5-Fluoroisatin--dimethyl sufoxide (1/1)
C10H10FNO3S
Acta Crystallographica Section E (2007) 63, 8 o3576-o3576
a=8.2828(13)Å b=8.3702(13)Å c=8.7613(14)Å
α=91.326(2)° β=117.099(2)° γ=97.337(2)°
5-Fluoro-3-hydroxy-3-(nitromethyl)-1H-indol-2(3H)-one
C9H7FN2O4
Acta Crystallographica Section E (2007) 63, 8 o3577-o3577
a=7.9400(8)Å b=15.7867(16)Å c=7.2980(8)Å
α=90° β=105.536(2)° γ=90°
7-Fluoroisatin--1,4-dioxane (1/1)
C12H12FNO4
Acta Crystallographica Section E (2007) 63, 8 o3574-o3574
a=11.5274(3)Å b=8.6508(2)Å c=12.1738(4)Å
α=90° β=106.701(3)° γ=90°
C20H20Cl2N4Ru
C20H20Cl2N4Ru
Acta Crystallographica Section C (1995) 51, 1 40-42
a=15.664(2)Å b=15.664(2)Å c=16.970(2)Å
α=90° β=90° γ=90°
5-fluorouracil--thymine
C4.48H4.45F0.52N2O2,C4.30H3.91F0.70N2O2
Acta Crystallographica Section C (2006) 62, 7 o412-o415
a=19.3785(15)Å b=5.9918(5)Å c=20.0293(15)Å
α=90.00° β=117.8130(10)° γ=90.00°
5-fluorouracil, thymine
C4.33H3.99F0.67N2O2,C4.24H3.73F0.76N2O2
Acta Crystallographica Section C (2006) 62, 7 o412-o415
a=19.235(3)Å b=5.9683(8)Å c=20.042(3)Å
α=90.00° β=118.216(2)° γ=90.00°
5-fluorouracil, thymine
C4.45H4.36F0.55N2O2,C4.31H3.94F0.69N2O2
Acta Crystallographica Section C (2006) 62, 7 o412-o415
a=19.856(11)Å b=5.946(3)Å c=20.073(11)Å
α=90.00° β=117.660(8)° γ=90.00°
5-fluorocytosine hemipentahydrate
2(C4H4FN3O),5(H2O)
Crystal Growth & Design (2006) 6, 2 481-487
a=12.2384(8)Å b=9.4254(6)Å c=13.8727(9)Å
α=90.00° β=111.3910(10)° γ=90.00°
C24H26Cl2N8O8Ru
C24H26Cl2N8O8Ru
Inorganic chemistry (2006) 45, 23 9580-9586
a=52.613(3)Å b=10.3927(7)Å c=15.8084(10)Å
α=90.00° β=102.6750(10)° γ=90.00°
C24H20BrF3N2O4
C24H20BrF3N2O4
Journal of Organic Chemistry (2012) 77, 6703-6727
a=16.6075(12)Å b=15.5958(11)Å c=9.3671(7)Å
α=90.00° β=105.497(2)° γ=90.00°
C22H18BrF3N2O4S
C22H18BrF3N2O4S
Journal of Organic Chemistry (2012) 77, 6703-6727
a=14.066(2)Å b=8.7343(13)Å c=18.513(3)Å
α=90.00° β=93.425(2)° γ=90.00°
C22H29BrN2O2
C22H29BrN2O2
Journal of Organic Chemistry (2012) 77, 6703-6727
a=9.6156(18)Å b=10.448(2)Å c=12.197(2)Å
α=86.817(3)° β=74.115(3)° γ=62.824(3)°
C26H21NO
C26H21NO
Journal of Organic Chemistry (2013) 78, 10938-10946
a=9.5467(2)Å b=14.4083(4)Å c=13.2429(4)Å
α=90.00° β=92.938(3)° γ=90.00°
5-fluorouracil
C4H3FN2O2
Journal of the American Chemical Society (2005)
a=8.6329(12)Å b=9.1560(13)Å c=12.5796(18)Å
α=99.119(2)° β=100.021(3)° γ=90.017(2)°
5-fluorouracil
C4H3FN2O2
Journal of the American Chemical Society (2005)
a=5.1540(16)Å b=15.001(5)Å c=6.654(2)Å
α=90.00° β=110.336(5)° γ=90.00°
5-fluorouracil form II
C4H3FN2O2
Journal of the American Chemical Society (2005)
a=5.0433(12)Å b=14.935(3)Å c=6.6049(15)Å
α=90.00° β=108.884(4)° γ=90.00°
C42H40O2Si2
C42H40O2Si2
Journal of the American Chemical Society (2003) 125, 15163-15173
a=7.2034(8)Å b=9.7662(10)Å c=12.7749(14)Å
α=82.283(2)° β=85.747(2)° γ=74.337(2)°
?
C42H40O2Si2
Journal of the American Chemical Society (2003) 125, 15163-15173
a=24.837(2)Å b=9.829(2)Å c=29.206(3)Å
α=90° β=96.53(8)° γ=90°
?
C42H40O2Si2
Journal of the American Chemical Society (2003) 125, 15163-15173
a=42.404(7)Å b=9.581(3)Å c=26.311(5)Å
α=90° β=96.37(2)° γ=90°
Bis-ethylene-dithiotetrathiafulvalene nitrobenzene gallium salt
C52H40GaNO15S32
Journal of the American Chemical Society (2002) 124, 12430-12431
a=10.3547(4)Å b=20.1508(7)Å c=35.5424(12)Å
α=90.00° β=92.5710(10)° γ=90.00°
Bis-ethylene-dithiotetrathiafulvalene pyridine gallium salt
C51H40GaNO13S32
Journal of the American Chemical Society (2002) 124, 12430-12431
a=10.3605(9)Å b=19.9645(17)Å c=35.428(3)Å
α=90.00° β=92.760(2)° γ=90.00°
Bis-ethylene-dithiotetrathiafulvalene pyridine gallium salt
C52H24Ga1O13S32
Journal of the American Chemical Society (2002) 124, 12430-12431
a=10.2588(1)Å b=19.7015(1)Å c=34.9512(3)Å
α=90° β=93.3665(4)° γ=90°
C24H65F14N7O7Si2
C24H65F14N7O7Si2
Journal of the American Chemical Society (2004) 126, 12395-12402
a=14.0345(9)Å b=15.9137(10)Å c=17.6318(11)Å
α=90.00° β=96.2392(45)° γ=90.00°
C48H116Br14N14O6
C48H116Br14N14O6
Journal of the American Chemical Society (2004) 126, 12395-12402
a=11.2538(4)Å b=18.0137(8)Å c=20.9088(8)Å
α=74.548(3)° β=82.221(2)° γ=73.058(3)°
C48H120Cl12N14O9
C48H120Cl12N14O9
Journal of the American Chemical Society (2004) 126, 12395-12402
a=11.2494(8)Å b=16.2958(12)Å c=21.1945(19)Å
α=78.3122(27)° β=85.1281(32)° γ=82.6143(40)°
C69H87Cl6N7O12S6
C69H87Cl6N7O12S6
Journal of the American Chemical Society (2004) 126, 12395-12402
a=16.3404(23)Å b=16.3404(23)Å c=28.0178(27)Å
α=90.00° β=90.00° γ=120.00°
Yttrium(tris(3,5-dimethylpyrazolyl)methane trichloride
C20H28Cl3N8Y
Inorganic Chemistry (2007) 46, 1856-1864
a=9.5040(6)Å b=16.3094(10)Å c=17.1537(6)Å
α=90.00° β=94.378(3)° γ=90.00°
Samarium(tris(3,5-dimethylpyrazolyl)methanetrichloride tetrahydrofuranate
C24H38Cl3N6O2Sm
Inorganic Chemistry (2007) 46, 1856-1864
a=10.5541(16)Å b=13.335(2)Å c=21.004(3)Å
α=90.00° β=90.00° γ=90.00°
Yttrium(tris(3,5-dimethylpyrazolyl)methane tris-(trifluoromethanesulfonate)
C35H54F9N6O13S3Y
Inorganic Chemistry (2007) 46, 1856-1864
a=28.698(3)Å b=19.426(2)Å c=19.807(2)Å
α=90.00° β=97.185(2)° γ=90.00°
Holmium(tris(3,5-dimethylpyrazolyl)methane) tris-(trifluoromethanesulfonate)
C31H46F9HoN6O12S3
Inorganic Chemistry (2007) 46, 1856-1864
a=29.2750(2)Å b=19.6570(10)Å c=19.8299(15)Å
α=90.00° β=95.481(3)° γ=90.00°
Neodymium(tris(3,5-dimethylpyrazolyl)methane tris-(2,6-dimethylphenoxide)
C52H73N6NdO6
Inorganic Chemistry (2007) 46, 1856-1864
a=12.5317(11)Å b=16.2143(14)Å c=16.3503(14)Å
α=60.7790(10)° β=77.2050(10)° γ=82.5080(10)°
Samarium(tris(3,5-dimethylpyrazolyl)methane tris-(2,6-dimethylphenoxide)
C52H73N6O6Sm
Inorganic Chemistry (2007) 46, 1856-1864
a=12.4975(8)Å b=16.2324(10)Å c=16.3598(10)Å
α=60.6900(10)° β=77.2960(10)° γ=82.4930(10)°
C34H34F12N6O3P2Ru
C34H34F12N6O3P2Ru
Inorganic Chemistry (2003) 42, 7704-7706
a=12.241(2)Å b=39.105(8)Å c=17.690(4)Å
α=90.00° β=90.00° γ=90.00°
5-fluorocytosine 2,2,2-trifluoroethanol
C4H4FN3O,C2H3F3O
Crystal Growth & Design (2006) 6, 2 481-487
a=11.1490(9)Å b=9.5914(8)Å c=8.5221(7)Å
α=90.00° β=108.1390(10)° γ=90.00°
5-fluorocytosine monohydrate
C4H4FN3O,H2O
Crystal Growth & Design (2006) 6, 2 481-487
a=7.3871(6)Å b=9.3940(8)Å c=17.5787(15)Å
α=90.00° β=98.608(2)° γ=90.00°
5-fluorocytosine monohydrate II
C4H4FN3O,H20
Crystal Growth & Design (2006) 6, 2 481-487
a=4.1026(5)Å b=8.2731(10)Å c=9.9191(12)Å
α=110.036(2)° β=100.460(2)° γ=96.710(2)°
5-fluorocytosine Form II
C4H4FN3O
Crystal Growth & Design (2006) 6, 2 481-487
a=4.0629(4)Å b=9.5211(9)Å c=12.7386(12)Å
α=90.00° β=92.986(2)° γ=90.00°
5-fluorocytosine hemipentahydrate
2(C4H4FN3O),5(H2O)
Crystal Growth & Design (2006) 6, 2 481-487
a=12.2384(8)Å b=9.4254(6)Å c=13.8727(9)Å
α=90.00° β=111.3910(10)° γ=90.00°
5-fluorocytosine methanol solvate 2/1
2(C4H4FN3O),CH4O
Crystal Growth & Design (2006) 6, 2 481-487
a=8.4486(9)Å b=9.2898(10)Å c=16.1042(18)Å
α=90.00° β=97.371(2)° γ=90.00°
1-nitro-2,4-Dichlorobenzene
C6H3Cl2NO2
Crystal Growth & Design (2008) 8, 1 24
a=20.682(3)Å b=3.7484(5)Å c=20.961(3)Å
α=90.00° β=118.235(2)° γ=90.00°
1-nitro-2,5-dichlorobenzene
C6H3Cl2NO2
Crystal Growth & Design (2008) 8, 1 24
a=7.1403(8)Å b=7.2638(8)Å c=8.2418(9)Å
α=72.781(2)° β=70.300(2)° γ=66.349(2)°
1-Chloro-3,4-dinitrobenzene beta polymorph
C6H3ClN2O4
Crystal Growth & Design (2008) 8, 1 24
a=7.554(3)Å b=7.821(3)Å c=13.453(5)Å
α=90.00° β=96.307(7)° γ=90.00°
1-nitro-3,4-dichlorobenzene
C6H3Cl2NO2
Crystal Growth & Design (2008) 8, 1 24
a=27.9342(19)Å b=27.9342(19)Å c=3.7655(5)Å
α=90.00° β=90.00° γ=90.00°
1-Chloro-3,4-dinitrobenzene gamma polymorph
C6H3ClN2O4
Crystal Growth & Design (2008) 8, 1 24
a=5.5245(11)Å b=11.778(2)Å c=11.939(2)Å
α=90.00° β=90.00° γ=90.00°
Cyanuric acid dihydrate
C3H7N3O5
Crystal Growth & Design (2005) 5, 3 983
a=12.278(2)Å b=6.6757(11)Å c=8.6678(14)Å
α=90.00° β=115.239(2)° γ=90.00°
Cyanuric acid DMF solvate
C6H10N4O4
Crystal Growth & Design (2005) 5, 3 983
a=6.297(4)Å b=7.674(4)Å c=10.557(6)Å
α=74.940(8)° β=87.597(9)° γ=67.677(8)°
Beta resoryclic acid form I
C7H6O4
Crystal growth & design (2011) 11, 1 210-220
a=23.1978(4)Å b=5.5469(1)Å c=5.1980(1)Å
α=90° β=92.215(1)° γ=90°
Beta resoryclic acid hemihydrate
2(C7H6O4),H2O
Crystal growth & design (2011) 11, 1 210-220
a=7.0270(4)Å b=9.5449(4)Å c=11.1763(5)Å
α=96.684(4)° β=104.319(5)° γ=98.903(4)°
Beta resoryclic DMSO hemisolvate
2(C7H6O4),C2H6OS
Crystal growth & design (2011) 11, 1 210-220
a=6.39832(12)Å b=11.7099(3)Å c=23.2362(5)Å
α=90° β=90° γ=90°
Beta resoryclate pyridinium salt
C7H5O4,C5H6N
Crystal growth & design (2011) 11, 1 210-220
a=11.7363(4)Å b=8.5691(2)Å c=11.8310(4)Å
α=90° β=115.973(5)° γ=90°
C4H4N2O3
C4H4N2O3
Crystal Growth & Design (2004) 4, 5 979
a=6.7305(18)Å b=14.029(4)Å c=6.2309(16)Å
α=90.00° β=116.368(4)° γ=90.00°
C7H8N2O3
C7H8N2O3
Crystal Growth & Design (2004) 4, 5 979
a=8.0309(14)Å b=11.980(2)Å c=7.8139(13)Å
α=90.00° β=107.038(3)° γ=90.00°
C4H4N2O3
C4H4N2O3
Crystal Growth & Design (2004) 4, 5 979
a=8.0828(11)Å b=12.5828(16)Å c=9.7644(13)Å
α=90.00° β=96.150(2)° γ=90.00°
3,4,5-trihydroxybenzoic acid
C7H6O5
Crystal growth & design (2013) 13, 1 19-23
a=25.685(3)Å b=4.9273(5)Å c=11.2508(12)Å
α=90° β=106.234(2)° γ=90°
Gallic acid
C7H6O5
Crystal growth & design (2013) 13, 1 19-23
a=5.2303(1)Å b=5.26495(12)Å c=24.7927(4)Å
α=90° β=102.1116(17)° γ=90°
Gallic acid
C7H6O5,H2O
Crystal growth & design (2013) 13, 1 19-23
a=7.60719(9)Å b=3.64133(4)Å c=26.7915(4)Å
α=90° β=98.4212(11)° γ=90°
Gallic acid
C7H6O5
Crystal growth & design (2013) 13, 1 19-23
a=7.31853(19)Å b=8.2536(2)Å c=11.7148(3)Å
α=100.4719(12)° β=90.2335(17)° γ=90.9844(17)°
4-dimethylaminopyridinium maleate
C7H11N2,C4H3O4
Crystal Growth & Design (2009) 9, 6 2881
a=13.127(3)Å b=7.599(2)Å c=12.576(3)Å
α=90.00° β=114.237(4)° γ=90.00°
4-dimethylaminopyridinium terephthalate
C7H11N2,0.5(C8H4O4)
Crystal Growth & Design (2009) 9, 6 2881
a=6.9285(7)Å b=15.7989(16)Å c=9.6739(10)Å
α=90.00° β=110.646(2)° γ=90.00°
4-Dimethylaminopyridinium fumarate-fumaric
C7H11N2,0.5(C4H4O4),0.5(C4H2O4)
Crystal Growth & Design (2009) 9, 6 2881
a=7.4036(13)Å b=8.1567(14)Å c=10.1469(17)Å
α=81.381(3)° β=89.228(3)° γ=70.789(3)°
4-Dimethylaminopyridinium phthalate
C7H11N2,C8H5O4
Crystal Growth & Design (2009) 9, 6 2881
a=22.130(3)Å b=8.7473(11)Å c=15.3325(19)Å
α=90.00° β=111.525(2)° γ=90.00°
4-dimethylaminopyridinium isophthalate
C7H11N2,0.5(C8H4O4)
Crystal Growth & Design (2009) 9, 6 2881
a=18.070(3)Å b=31.806(5)Å c=6.8941(10)Å
α=90.00° β=90.00° γ=90.00°
Pyridine fumaric acid
2(C5H5N1),C4H4O4
Crystal Growth & Design (2009) 9, 6 2881
a=3.8195(6)Å b=10.2834(15)Å c=17.067(3)Å
α=90.00° β=91.436(3)° γ=90.00°
1,3,5-trihydroxybenzene
C6H6O3
Crystal growth & design (2013) 13, 9 4071-4083
a=12.1207(6)Å b=3.80651(13)Å c=13.1647(6)Å
α=90° β=115.478(6)° γ=90°
Pyrogallol_tetartohydrate
4(C6H6O3),H2O
Crystal growth & design (2013) 13, 9 4071-4083
a=24.6058(6)Å b=24.6058(6)Å c=3.8524(3)Å
α=90° β=90° γ=90°
{Me2In[OCH2CH2N(Me)2]}2
C12H32In2N2O2
Inorganic chemistry (2007) 46, 22 9473-9480
a=11.6733(14)Å b=15.6152(18)Å c=10.3060(12)Å
α=90.00° β=90.00° γ=90.00°
{Me2In[N(Me)2CH2CH(Me)O]}2
C14H36In2N2O2
Inorganic chemistry (2007) 46, 22 9473-9480
a=15.5563(12)Å b=8.1075(6)Å c=16.7231(13)Å
α=90.00° β=96.9500(10)° γ=90.00°
{Me2In[OC(Me)2CH2OMe]}2
C14H34In2O4
Inorganic chemistry (2007) 46, 22 9473-9480
a=8.3096(9)Å b=15.0739(16)Å c=8.7685(9)Å
α=90.00° β=112.743(2)° γ=90.00°
{Me2In[N(Me)2CH2CHOCH2N(Me)2]}2
C18H46In2N4O2
Inorganic chemistry (2007) 46, 22 9473-9480
a=8.3820(8)Å b=8.4014(8)Å c=10.1223(10)Å
α=66.1840(10)° β=85.316(2)° γ=82.575(2)°
7-Fluoroisatin--dimethyl sulfoxide (1/1)
C10H10FNO3S
Acta Crystallographica Section E (2007) 63, 8 o3575-o3575
a=7.4917(12)Å b=8.4911(14)Å c=8.9542(15)Å
α=106.207(2)° β=98.648(2)° γ=96.242(3)°
Bis-ethylene-dithiotetrathiafulvalene nitrobenz gallium salt
C52H40GaNO15S32
Journal of the American Chemical Society (2002) 124, 12430-12431
a=10.2782(3)Å b=19.8733(6)Å c=35.0431(11)Å
α=90.00° β=93.4230(10)° γ=90.00°
C24H51I14N7
C24H51I14N7
Journal of the American Chemical Society (2004) 126, 12395-12402
a=11.4033(12)Å b=11.5662(12)Å c=21.966(2)Å
α=85.670(2)° β=83.181(2)° γ=61.557(2)°
5-fluorocytosine Form I
C4H4FN3O
Crystal Growth & Design (2006) 6, 2 481-487
a=6.6387(4)Å b=6.6387(4)Å c=23.471(3)Å
α=90.00° β=90.00° γ=90.00°